Compare ELTX & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | TRAK |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 156.5M |
| IPO Year | 2014 | 1996 |
| Metric | ELTX | TRAK |
|---|---|---|
| Price | $11.79 | $8.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 138.3K | 136.5K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | ★ 38.94 | 20.69 |
| EPS | N/A | ★ 0.18 |
| Revenue | $2,301,000.00 | ★ $21,007,076.00 |
| Revenue This Year | N/A | $6.61 |
| Revenue Next Year | N/A | $10.04 |
| P/E Ratio | ★ N/A | $46.61 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $4.60 | $8.11 |
| 52 Week High | $14.93 | $23.72 |
| Indicator | ELTX | TRAK |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 29.95 |
| Support Level | $7.78 | $8.11 |
| Resistance Level | $12.52 | $9.02 |
| Average True Range (ATR) | 1.12 | 0.33 |
| MACD | 0.05 | 0.04 |
| Stochastic Oscillator | 51.27 | 15.05 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
ReposiTrak Inc is a software-as-a-service (SaaS) company based in Murray, Utah, specializing in supply chain management solutions for retailers, suppliers, and wholesalers, prominently in the food industry. The company offers three main product suites: ReposiTrak Compliance Management, ReposiTrak Traceability Network, and ReposiTrak Supply Chain Solutions. These platforms help customers comply with food safety regulations, manage supplier compliance documentation, trace products through the supply chain, and optimize supply chain operations. The company derives revenue from five sources: (i) subscription fees, (ii) transaction-based fees, (iii) professional services fees, (iv) license fees, and (v) hosting and maintenance fees.